Professional Overview

Ken Stineman is a seasoned technology executive currently serving as the Chief Technology Officer (CTO) in San Jose, California. His key expertise areas include technology, operations, and privacy, with a strong industry focus on biotechnology, telemedicine, and healthcare.

Experience Summary

Current Role

As the CTO at Double Helix LLC and COO at Navvisa, Ken oversees technology, operations, and privacy, driving strategic growth and innovation. His current position involves leading cross-functional teams, developing and implementing technology roadmaps, and ensuring compliance with regulatory requirements.

Career Progression

Ken's career spans over three decades, with notable previous roles including Sr. Director, Computing & IT; Privacy Officer; Security Officer at Genomic Health, Inc., Associate Director, Software Engineering at Incyte Corporation, Software Manager at Synteni, Inc., and Performance Engineer at Intel Corporation. Throughout his career, Ken has demonstrated significant growth, from technical roles to executive positions, showcasing his ability to adapt and lead in diverse environments.

Areas of Expertise

Ken possesses a unique blend of industry-specific skills, including biotechnology, telemedicine, and healthcare, as well as technical competencies in software engineering, computing, and IT. His leadership and management capabilities are evident in his ability to drive strategic initiatives, lead cross-functional teams, and ensure regulatory compliance.

Professional Impact

Although specific projects or initiatives are not detailed, Ken's contributions to the biotechnology, telemedicine, and healthcare industries are significant, given his extensive experience and executive roles. His leadership has likely driven innovation, growth, and compliance in these sectors.

Conclusion

Ken Stineman's professional trajectory is marked by significant growth, from technical roles to executive positions, demonstrating his ability to adapt and lead in diverse environments. Currently, he is focused on driving strategic growth and innovation as a CTO and COO. His value proposition lies in his unique blend of industry-specific skills, technical competencies, and leadership capabilities, making him a valuable asset to organizations in the biotechnology, telemedicine, and healthcare sectors.